Chronic Leukemia Perspective

• Signal Disruption: Targeted Therapies for CLL: New Targets, New Approaches   Recognized hematologists discuss current research initiatives for CLL and explain the advances that are moving investigators closer to a cure.
  Medscape TV, January 25, 2021
• Highlights in Chronic Lymphocytic Leukemia From ASH 2020   Dr William Wierda from MD Anderson reviews key studies on chronic lymphocytic leukemia therapies from ASH 2020, including the phase 3 UNITY trial, next-generation BTK inhibitors, and CAR-T therapy.
  Medscape, December 28, 2020
• Signal Disruption: Targeted Therapies for CLL: The Greater Good   Caregivers, case managers, and CLL patients from the James Cancer Hospital at OSU discuss the benefits and challenges of enrollment on a clinical trial.
  Medscape TV, December 15, 2020
• Signal Disruption: Targeted Therapies for CLL: What Patients Want   Experts and CLL patients discuss the factors to consider in choosing the optimal first-line therapy, including efficacy, side effects, and quality of life.
  Medscape TV, November 03, 2020
• Signal Disruption: Targeted Therapies for CLL: Choosing From the Combo Menu   Providers from OSU’s James Cancer Hospital discuss combination therapies and the emerging role of fixed-duration therapies in the treatment of CLL.
  Medscape TV, September 30, 2020
• A 70-Year-Old Man With Splenomegaly A 70-year-old man presents with splenomegaly. What is most likely to be found upon staining his cells?
  Osmosis, August 07, 2020
• A 71-Year-Old Man With Malaise and Weight Loss A 71-year-old man presents with fatigue and malaise over the past three months. He also reports a 10 lbs weight loss. What's causing these symptoms?
  Osmosis, June 26, 2020
• Signal Disruption: Flipping the Switch   Hematologists from Ohio State University discuss ongoing trials and emerging developments in firstline treatment for chronic lymphocytic leukemia, including targeted and novel combination therapies.
  Medscape TV, June 24, 2020
• EHA 2020 Read clinically focused news coverage of key developments from EHA 2020
  Medscape Oncology, June 15, 2020
• With 'Horrendous' Decisions Afoot in COVID-19, Teams Are Key   With the COVID-19 pandemic stressing physicians and clinical teams, Tait Shanafelt, a physician wellness expert, says institutions need to provide clear, transparent information and support.
  Medscape, April 24, 2020
• Treatment Tips in Chronic Lymphocytic Leukemia A conversation with CLL specialists Drs Anthony Mato and Lindsey Roeker about the novel agents acalabrutinib, obinutuzumab, and venetoclax.
  Medscape Oncology, April 14, 2020
• Signal Disruption: Targeted Therapies for CLL   Hematologists from Ohio State University discuss ongoing trials and emerging developments in firstline treatment for chronic lymphocytic leukemia, including targeted and novel combination therapies.
  Medscape TV, April 02, 2020
• Targeted Therapy for CLL: Beyond Chemotherapy: New Targeted Agents   Many targeted therapies have improved outcomes over chemotherapy for CLL. BTK inhibition, BCL-2 inhibitors, and monoclonal antibodies are discussed.
  Medscape TV, February 13, 2020
• CLL Highlights From ASH 2019   Dr William Wierda of MD Anderson Cancer Center reviews key studies on chronic lymphocytic leukemia therapies presented at the 2019 American Society of Hematology (ASH) meeting in Orlando, Florida.
  Medscape, January 06, 2020
• The 8 Most Notable Cancer Clinical Trials of 2019 Expert oncologists share the trials most likely to change your approach to patient care going forward.
  Medscape Oncology, December 13, 2019
• Emerging Trends: Targeted Therapy for CLL: FISHing for Risk Markers   The molecular profile of the disease is a crucial prognostic indicator in CLL. Oncologists discuss markers to distinguish low-risk from high-risk disease.
  Medscape TV, December 12, 2019
• Chronic Lymphocytic Leukemia: 5 Things to Know The most common adult leukemia has seen a rush of new evidence in recent years. Here are some of the highlights.
  Medscape Oncology, September 24, 2019
• Emerging Trends: Targeted Therapy for CLL   MD Anderson hematologists discuss recent developments in treatment options for chronic lymphocytic leukemia, including monoclonal antibodies, targeted therapies, and small-molecule inhibitors.
  Medscape TV, September 16, 2019
• EHA 2019 Read clinically focused news coverage of key developments from EHA 2019
  Medscape Oncology, June 10, 2019
• BSH 2019 Read clinically focused news coverage of key developments from BSH 2019
  Medscape Oncology, April 01, 2019